---
$id: https://graph.org.ai/products/commodity/51161555
$type: Product
source: UNSPSC
code: "51161555"
title: "Seratrodast"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Seratrodast

**UNSPSC Code**: 51161555
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-asthmatic agent with the molecular formula C22H26O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4U58JM421N, chemically known as benzeneheptanoic acid, zeta-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-, (+-)- but generally known as seratrodast, which bears US NIH Compound Identifier 2449. European Medicines Agency schedules Seratrodast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10490MIG. The term SERATRODAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 8 No. 3 1994, List 34). World Health Organization schedules seratrodast in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule seratrodast under HS 29183000 and SITC 51395. As of Q4 2014, SERATRODAST remains the US FDA Preferred Term for this commodity. Seratrodast bears US NLM identifiers UMLS ID C0050339 and NCI Concept Code C90671. SMILES: O=C1C(=C(C(=O)C(=C1C)C)C)C(CCCCCC(=O)O)C1CCCCC1.

